International Trade committee  I'd like to add two comments. First, Professor Evenett mentioned the example of South Korea. While I largely agree that South Korea hasn't been able to vaccinate as many people as some other countries have, SK Bioscience in South Korea is indeed a manufacturer of AstraZeneca's va

International Trade committee  Thank you. It's fair to say that there are many facilities globally, some of which—and I'm underscoring the words “some of which”—may have the required equipment to start manufacturing COVID vaccines of different types, but equipment is only one part of the multi-dimensional ne

International Trade committee  I'm sorry about that, yes. Having trained chemistry, manufacturing and control staff and having quality management specialists is an important prerequisite. Even when we have facilities around the world that have equipment to manufacture COVID vaccines, they do not necessarily h

International Trade committee  My viewpoint is that it's a very good initiative. For a large number of countries that either do not have the financing, the working capital, the size of the market or the ability to negotiate vaccine access for themselves, it does it collectively for them. In addition to this, i

International Trade committee  Thank you. Thank you to the members of this committee for giving me the opportunity to share my viewpoint on this very crucial topic. We acknowledge that there is an urgent need to further scale up the production of safe, efficacious COVID vaccines, but also to keep in mind the